Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18322542.
- Also identified by DOI 10.1038/ki.2008.34 and PMC identifier 2614447.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The major sphingolipid metabolite, sphingosine-1-phosphate (S1P), has important biological functions. S1P is the ligand for a family of five G-protein-coupled receptors with distinct signaling pathways that regulate angiogenesis, vascular maturation, immunity, chemotaxis, and other important biological pathways. Recently, clinical trials have targeted S1P receptors (S1PRs) for autoimmune diseases and transplantation and have generated considerable interest in developing additional, more selective compounds. This review summarizes current knowledge on the biology of S1P and S1PRs that forms the basis for future drug development and the treatment of kidney disease.
Medical subject headings
- Drug Design
- Kidney Diseases
- Lysophospholipids
- Receptors, Lysosphingolipid
- Sphingosine